| 1320 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | Overview | Immunizations and Respiratory Diseases |
National Center for Immunization and Respiratory Diseases (NCIRD). |
| MPEG | 0.625771 |
| death | 0.55111 |
| disability | 0.551483 |
| control | 0.550489 |
| different file formats | 0.967935 |
| branches | 0.603481 |
| NCIRD | 0.547036 |
| divisions | 0.607007 |
|
| Prevention | 0.551981 |
| PDF | 0.544221 |
| PPT | 0.677519 |
| immunization | 0.669086 |
| DOC | 0.617914 |
| Mission | 0.55223 |
| respiratory | 0.641602 |
|
CLICK HERE |
| 5468 |
Centers for Disease Control and Prevention |
Html |
en |
Nickel carbonyl - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7298 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease: Volume 9, 2012: 12_0005 |
CDC - Wide Page example description goes here |
| tumor cell growth | 0.453348 |
| follow-up period | 0.52187 |
| AMA PRA | 0.46781 |
| statin efficacy | 0.559366 |
| efficacious statins | 0.482791 |
| statin packs | 0.585933 |
| multivariable model | 0.45912 |
| initial statin medications | 0.543407 |
| statin medication | 0.597134 |
| statins efficacy | 0.51952 |
| Tel Aviv | 0.582069 |
| study follow-up period | 0.453783 |
| total follow-up time | 0.559561 |
| lower risk | 0.462594 |
| statin | 0.94679 |
| index date | 0.629947 |
| statin type | 0.519689 |
| incident cancer cases | 0.484053 |
| hydrophilic statins | 0.483438 |
| socioeconomic level | 0.45194 |
| statin dispensation | 0.612263 |
| nonpersistent statin users | 0.727091 |
| study | 0.563004 |
| overall cancer risk | 0.507605 |
|
| negative association | 0.495452 |
| non-Hodgkin lymphoma | 0.513148 |
| high-efficacy statins | 0.492567 |
| highest PDC quintile | 0.464437 |
| lower cancer risk | 0.499566 |
| statin types | 0.503878 |
| widespread statin consumption | 0.625628 |
| strong negative association | 0.451168 |
| statins therapy | 0.555081 |
| health maintenance organization | 0.458399 |
| initial statin therapy | 0.564675 |
| statin medications | 0.589135 |
| Tel Aviv University | 0.55451 |
| lipophilic statin users | 0.548899 |
| statin persistence | 0.509346 |
| statin users | 0.895727 |
| statin therapy | 0.836176 |
| relevant financial relationships | 0.510841 |
| statins | 0.926564 |
| initial statins therapy | 0.538685 |
| highest cancer risk | 0.514911 |
| hematopoietic cancer risk | 0.459421 |
| Sackler Faculty | 0.449283 |
| cancer risk | 0.730804 |
|
CLICK HERE |
| 8193 |
Centers for Disease Control and Prevention |
Html |
en |
Fragile X Syndrome (FXS), Home - NCBDDD |
null |
| FXS | 0.391619 |
| well-being | 0.357558 |
| CDC | 0.436205 |
| fragile X-associated disorders | 0.857587 |
| complex condition | 0.487313 |
| health | 0.338767 |
| individuals | 0.335947 |
|
| people | 0.373961 |
| Researchers | 0.336611 |
| fragile x syndrome | 0.959689 |
| common causes | 0.522262 |
| Real stories | 0.486308 |
| conditions | 0.338403 |
|
CLICK HERE |
| 8841 |
Centers for Disease Control and Prevention |
Html |
en |
Tourette Syndrome: New Treatment Option | CDC Features |
null |
| CDC | 0.473702 |
| Texas A&M University | 0.508582 |
| Arch Gen Psychiatry | 0.498805 |
| effective treatment | 0.464296 |
| promising treatment | 0.470347 |
| different behavior | 0.467593 |
| tics | 0.916532 |
| sudden twitches | 0.470408 |
| new skills | 0.460324 |
| tourette syndrome | 0.794102 |
| things | 0.461143 |
| Behavior therapy | 0.459758 |
| Tourette disorder | 0.47194 |
| new behavior | 0.544388 |
| Obsessive Compulsive Disorder | 0.523138 |
| health professionals | 0.50727 |
| severe tics | 0.620718 |
| promising behavioral treatment | 0.533345 |
| additional diagnosed condition | 0.522891 |
| specific treatment | 0.461537 |
| Tourette Syndrome Association | 0.537401 |
| Comprehensive Behavioral Intervention | 0.5146 |
| large scale studies | 0.503427 |
| health problems | 0.463976 |
|
| specific needs | 0.460242 |
| person | 0.507042 |
| slow rhythmic breathing | 0.508003 |
| Attention Deficit/Hyperactivity Disorder | 0.52238 |
| stressful situations | 0.459238 |
| CBIT outreach | 0.565366 |
| real treatment option | 0.520989 |
| throat clearing tic | 0.530402 |
| Tourette Association | 0.472491 |
| behavioral therapy | 0.516103 |
| grunting sound | 0.471896 |
| CBIT treatment | 0.591049 |
| treatment option | 0.527179 |
| Dr. Doug Woods | 0.502114 |
| CBIT | 0.799535 |
| spinal cord | 0.464647 |
| systematic way | 0.461771 |
| people | 0.607339 |
| Dr. Leon Dure | 0.506464 |
| randomized controlled trial | 0.496159 |
| education professionals | 0.466852 |
| A. L. | 0.496946 |
| D. W. | 0.498226 |
| J. T. | 0.492089 |
|
CLICK HERE |
| 10754 |
Centers for Disease Control and Prevention |
Html |
en |
For Researchers - Pregnancy Risk Assessment Monitoring System - Reproductive Health |
PRAMS for Researchers |
| PRAMS Topic Reference | 0.637775 |
| following variables | 0.228012 |
| single pdf file | 0.287838 |
| PRAMS states | 0.563758 |
| PRAMS Research Dataset | 0.665197 |
| response rate threshold | 0.317534 |
| PRAMS Set-up | 0.528474 |
| SAS Complex Survey | 0.266654 |
| SPSS Complex Samples | 0.273361 |
| standardized optional questions | 0.251215 |
| data sets | 0.4129 |
| application form | 0.289667 |
| PRAMS data | 0.801178 |
| additional Questionnaire Variables | 0.351027 |
| individual state approval | 0.2745 |
|
| PRAMS complex survey | 0.659059 |
| PRAMS questionnaire | 0.655861 |
| coordinator contact information | 0.257643 |
| PRAMS Analytic Research | 0.906668 |
| birth certificate variables | 0.51158 |
| PRAMS | 0.921113 |
| data sharing agreement | 0.533202 |
| Standard Question Lists | 0.259535 |
| additional Birth Certificate | 0.256067 |
| Complete proposals | 0.207574 |
| review date | 0.288996 |
| PRAMS coordinators | 0.518497 |
| Analytic Research File | 0.514265 |
| Proposal Guidelines | 0.327384 |
| Proposal reviews | 0.20841 |
|
CLICK HERE |
| 12495 |
Centers for Disease Control and Prevention |
Video |
en |
February 2014 ACIP Meeting -- Pneumococcal Conjugate Vaccine (PCV) -- Part 1 |
Introduction, Update on Effectiveness and Impact of PCV13 use among U.S. Children, and GRADE for 3-dose PCV13 schedules.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
pneumococcal conjugate vaccine, PCV13, PC13 use, PC13 schedules, GRADE |
| PCV | 0.482323 |
| Pneumococcal Conjugate Vaccine | 0.984626 |
|
|
CLICK HERE |
| 13646 |
Centers for Disease Control and Prevention |
Html |
en |
Clinical Inquiries Received by CDC Regarding Suspected EbolaVirus Disease in Children - United States, July 9, 2014-January 4,2015 |
Alyson B. Goodman, MD1,2; Elissa Meites, MD1,3; Erica H. Anstey, PhD1,4; Kathleen E. |
| CDC | 0.364536 |
| common pediatric illnesses | 0.295976 |
| health care provider | 0.272164 |
| Ebola virus test | 0.474655 |
| Ebola virus | 0.593198 |
| Ebola outbreak | 0.441782 |
| children | 0.395708 |
| time Ebola | 0.473266 |
| health care providers | 0.760637 |
| Ebola online | 0.406895 |
| epidemiologic risk factors | 0.640484 |
| public health officials | 0.501799 |
| Emergency Operations Center | 0.300271 |
| health care facilities | 0.33088 |
| pediatric Ebola-related inquiries | 0.270977 |
| clinical consultation service | 0.316121 |
| state public health | 0.266437 |
| Ebola risk | 0.421017 |
| clinical inquiries | 0.276109 |
| Ebola | 0.968609 |
| health care needs | 0.265135 |
| Ebola virus disease | 0.517346 |
| routine pediatric care | 0.252805 |
| Ebola assessment | 0.613796 |
| United States | 0.423047 |
|
| epidemiologic risk factor | 0.426227 |
| CDC Laboratory Response | 0.293189 |
| pediatric Ebola case | 0.487911 |
| Pediatric clinical care | 0.276545 |
| pediatric Ebola assessments | 0.565279 |
| pediatric patients | 0.258553 |
| identifiable epidemiologic risk | 0.342342 |
| Ebola case | 0.612163 |
| domestic Ebola diagnoses | 0.5001 |
| Ebola virus RNA | 0.506001 |
| domestic Ebola case | 0.443854 |
| health departments | 0.294107 |
| pediatric clinical inquiries | 0.266402 |
| local health departments | 0.248839 |
| health care | 0.772661 |
| public health | 0.51525 |
| Ebola clinical consultation | 0.550915 |
| Ebola-affected country | 0.317557 |
| poorer clinical outcomes | 0.2982 |
| Alyson B. Goodman | 0.282946 |
| local public health | 0.337667 |
| Ebola patient | 0.478473 |
| Health care facility | 0.265831 |
| Ebola testing | 0.441049 |
|
CLICK HERE |
| 14322 |
Centers for Disease Control and Prevention |
Image |
null |
Radiation Emergencies and Pregnancy| Infographic |
null |
|
|
CLICK HERE |
| 15820 |
Centers for Disease Control and Prevention |
Html |
en |
Diabetes | Social Media | Resource Center | Diabetes |
Diabetes In The United States |
| MPEG | 0.276361 |
| PDF | 0.201634 |
| PPT | 0.326381 |
|
| email address | 0.716575 |
| DOC | 0.270026 |
| different file formats | 0.90859 |
|
CLICK HERE |